Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn - Mounjaro to be rolled out to only ...

Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The ...

Fewer than one in ten patients who meet the criteria for Mounjaro will be given it by the health service over the next three ...

Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

Actor and comedian Jim Gaffigan made sure his 50-pound weight loss was funny business, discussing the topic in his November ...

SURMOUNT-5’s results reflect those of multiple real-world studies, which have found that tirzepatide treatment results in ...